Biocare Medical acquires Empire Genomics

Biocare Medical, a provider of IHC and FISH instrumentation and reagents, announced the acquisition of Empire Genomics, a market leader in molecular biomarkers for cancer research and diagnostics. The acquisition expands Biocare Medical's molecular portfolio to over 1 million biomarkers.

“We are incredibly excited to welcome Empire Genomics to the Biocare Medical team.”empiregenomics.com

• 1 source
• empiregenomics.comBIOCARE MEDICAL Acquires Empire Genomics, Expanding Molecular Portfolio to Over 1 Million Biomarkers and Adding Rapid Biomarker Development to Lead Cancer Research - Empire GenomicsEmpire GenomicsNov 22, 2022

Summarized from public sources; check the original articles before acting on it.